Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCE | Q02156 | 1/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.60 |
| ▸ | PRKCA | P17252 | 1/20 | 0.60 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.59 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.59 |
| ▸ | SELP | P16109 | 1/20 | 0.56 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.56 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | FABP3 | P05413 | 1/20 | 0.55 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.54 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.54 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.53 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.53 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23123577 | 1.00 | PRKCE (0.60) | PRKCEPRKCQPRKCDPRKCAENPP2 | |
| SCHEMBL4451416 | 0.94 | LPAR3 (0.62) | PRKCEPRKCQPRKCDPRKCAENPP2 | |
| SCHEMBL4450733 | 0.94 | LPAR3 (0.62) | PRKCEPRKCQPRKCDPRKCAENPP2 | |
| SCHEMBL1613618 | 0.93 | PRKCA (0.61) | PRKCEPRKCQPRKCDPRKCAENPP2 | |
| SCHEMBL23123570 | 0.93 | PRKCA (0.61) | PRKCEPRKCQPRKCDPRKCAENPP2 | |
| SCHEMBL1613622 | 0.92 | SLC6A5 (0.60) | PRKCEPRKCQPRKCDPRKCAENPP2 | |
| SCHEMBL138219 | 0.87 | PRKCA (0.74) | PRKCEPRKCQPRKCDPRKCASLC6A5 | |
| SCHEMBL24217679 | 0.87 | PRKCA (0.74) | PRKCEPRKCQPRKCDPRKCASLC6A5 | |
| SCHEMBL21381523 | 0.87 | PRKCA (0.74) | PRKCEPRKCQPRKCDPRKCASLC6A5 | |
| SCHEMBL19411106 | 0.87 | PRKCA (0.74) | PRKCEPRKCQPRKCDPRKCASLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2280691-B1 | crystalline DOPC | MERCK PATENT GMBH (DE) | 2022-08-03 | — | — | EP | disclosed |
| US-8513446-B2 | Stable crystal modifications of DOPC | MERCK PATENT GMBH (DE) | 2013-08-20 | — | — | US | disclosed |
| US-20110086091-A1 | STABLE CRYSTAL MODIFICATIONS OF DOPC | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086091-A1 | STABLE CRYSTAL MODIFICATIONS OF DOPC | RAB5C, PHOSPHO1, DHCR7 | PRKCE 1533/4885PRKCQ 617/4885PRKCD 1034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.